Over the past decade, understanding of Crohn’s disease has evolved from symptom‑focused management to earlier, more individualized and objective treatment strategies. In this interview, Prof. Dr. med. Biedermann reflects on this progress and its implications for improving long‑term patient care. 1-3
Brightcove Video
VV-MEDMAT-133545
References
-
1. Gomollón F, et al. "3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management." J Crohns Colitis. 2017;11(1):3-25.
-
2. Turner D, et al. "STRIDE-II: An Update on Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target Strategies in IBD." Gastroenterology. 2021;160(5):1570–1583.
-
3. Gordon H et al. ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment. Journal of Crohn's and Colitis. 2024;18(10):1531–1555.